Federated Hermes
TNGX icon

Federated Hermes’s Tango Therapeutics TNGX Stock Holding History

Federated Hermes’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38M Buy
1,214,613
+1,214,259
+343,011% +$30M 0.05% 328
2026
Q1 		$7.41K Sell
354
-8
-2% -$111 ﹤0.01% 1859
2025
Q4 		$3.21K Hold
362
– – ﹤0.01% 1933
2025
Q3 		$3.04K Hold
362
– – ﹤0.01% 1992
2025
Q2 		$1.85K Sell
362
-7,221
-95% -$17.9K ﹤0.01% 1961
2025
Q1 		$10.4K Buy
+7,583
New +$18.6K ﹤0.01% 1798
2024
Q2 		– Sell
-67,115
Closed -$533K – 2135
2024
Q1 		$533K Buy
67,115
+66,959
+42,922% +$718K ﹤0.01% 1308
2023
Q4 		$1.54K Buy
+156
New +$1.35K ﹤0.01% 1949
2023
Q2 		– Sell
-412
Closed -$1.63K – 2221
2023
Q1 		$1.63K Buy
+412
New +$2.39K ﹤0.01% 2015

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Federated Hermes's TNGX Position: Q2 2026 in Review

Federated Hermes increased its Tango Therapeutics (TNGX) stake by 343,011% in Q2 2026, buying an estimated $30M and bringing the position to 1,214,613 shares worth $38M. The position accounts for 0.05% of the portfolio, ranked #328.

Federated Hermes first reported a position in TNGX in Q1 2023 and has held it in 9 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Federated Hermes held 1,214,613 shares of Tango Therapeutics worth $38M as of Q2 2026.
  • Federated Hermes bought 1,214,259 Tango Therapeutics shares in Q2 2026, an estimated $30M.
  • Tango Therapeutics made up 0.05% of Federated Hermes's portfolio in Q2 2026, its #328 holding.
  • Federated Hermes first reported a position in Tango Therapeutics in Q1 2023 and has held it in 9 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.